Clinical Trials Overview
Thursday, November 8th, 2007Every drug that makes it to the pharmacy shelf must leap over numerous hurdles, starting with experimentation in the lab, followed by clinical trials in humans and culminating with the scrutiny of the U.S. Food and Drug Administration (FDA), which must review and approve all proposed new medications for safety and effectiveness before they can be sold to consumers. The process can take upwards of 10 years, and clinical testing is the trial by fire that makes or breaks any prospective new drug.
Pharmaceutical companies also test drugs that have already been approved, to monitor long-term safety and effectiveness. Additional labeling claims or proposed new uses of drugs previously approved for commercial sale must be evaluated in subsequent clinical trials.
New medical devices and even new procedures and approaches to diagnosing or treating diseases must undergo clinical testing to prove their merit. A study might ask whether using a particular drug in addition to surgery is better than surgery alone, or whether earlier, more aggressive treatment of a condition produces a better outcome. Any question health care professionals might have about how best to diagnose and treat a medical condition may be addressed scientifically by a clinical trial.
Clinical trial results themselves must pass a test as well. Results of safety and/or efficacy must be “statistically significant”. That means a mathematical analysis of the results must show that the results obtained are highly likely to be “true” and not the result of chance.
Risks and benefits of taking part in a clinical tria
Why do people participate in clinical trials? Some people who are very ill or who are not responding to standard treatments join clinical trials in order to receive new, investigational treatment. They are hoping that this treatment, possibly a new drug, medical device or procedure, will work better for them than standard therapy. Others participate in clinical trials to contribute to medical science, while others take part for the chance to try the newest treatment that they hope will work better than the current standard.
Participation in a clinical trial brings a host of potential benefits and possible risks for the consumer. The benefits include access to new treatments otherwise unavailable as well as an opportunity to help others by contributing to medical research. Sometimes, it also means access to top medical care, although the majority of FDA approved clinical trails, are conducted in community practices. If a treatment proves effective, you, as the participant in the clinical trial, may be offered the treatment, even if you have been in the control group.
When you enroll in a clinical trial, however, you should be aware of the potential risks associated with the study. You may also be signing up for some inconveniences. The treatment may have side effects or produce adverse reactions with other medications or foods. You may receive a placebo (although they are not used in cancer trials), or you may receive the experimental treatment but not derive any benefit. If there is an existing effective therapy, weigh your options carefully in light of the fact that you may get only a placebo treatment. Another factor to keep in mind is that the design of the trial may require frequent trips to the study site, hospital stays, or difficult or uncomfortable procedures.
Clinical trials, at least late-stage trials, may not be as risky as most health care professionals and participants believe. An initial 1999 review of 25 studies found that outcomes were better overall for participants in Phase III clinical trials than in those who did not join a clinical trial. The surprising results suggest the need for a broader analysis; if confirmed, additional studies could address the reasons for the so-called “inclusion benefit.” It could be, for example, that volunteers for trials tend to be more conscientious about their health, or that the more attentive care provided in trials makes a significant difference.
Clinical trial sponsors may include government agencies, such as the National Institutes of Health (NIH); pharmaceutical or medical device companies; individual physicians; or health care institutions. Trials may be conducted in a variety of locations: hospitals, universities, doctors’ offices or community clinics.


